文献速递腹部CT

双能CT提高非富血供胰腺神经内分泌肿瘤与CA 19-9阴性胰腺导管腺癌的鉴别能力

Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas.
PubMed 文献 · Radiol Med · 2023-10-20

回顾性纳入26例非富血供胰腺神经内分泌肿瘤和39例CA 19-9阴性胰腺导管腺癌患者,评估双能CT鉴别价值;基于动静脉期归一化碘浓度的双能CT定量模型AUC为0.918,综合模型AUC为0.966,均高于定性模型和常规CT定量模型;两期归一化碘浓度较高与血供较丰富相关,有助于识别非富血供胰腺神经内分泌肿瘤。

要点

  • 双能CT定量模型基于动脉期和门静脉期归一化碘浓度,鉴别非富血供胰腺神经内分泌肿瘤与CA 19-9阴性胰腺导管腺癌的AUC为0.918。
  • 综合模型基于肿瘤位置及动脉期和门静脉期归一化碘浓度,AUC为0.966,高于定性模型(AUC 0.782)和常规CT定量模型(AUC 0.665)。
  • 动脉期和门静脉期归一化碘浓度较高与血供较丰富相关,有助于识别非富血供胰腺神经内分泌肿瘤。

核心结论

  • 动脉期和门静脉期归一化碘浓度较高与血供较丰富相关,可提高对非富血供胰腺神经内分泌肿瘤的识别能力。

研究设计与样本

  • 回顾性研究纳入26例病理证实的非富血供胰腺神经内分泌肿瘤和39例CA 19-9阴性胰腺导管腺癌患者,均于2019年6月至2021年12月治疗前接受对比增强双能CT检查。

诊断标准与关键数值

  • 双能CT定量模型基于动脉期和门静脉期归一化碘浓度,鉴别非富血供胰腺神经内分泌肿瘤与CA 19-9阴性胰腺导管腺癌的AUC为0.918(95%CI 0.852-0.985)。
  • 综合模型基于肿瘤位置及动脉期和门静脉期归一化碘浓度,AUC为0.966(95%CI 0.889-0.995)。
  • 定性模型基于肿瘤位置,AUC为0.782(95%CI 0.665-0.899)。
  • 常规CT定量模型基于动脉期归一化常规CT衰减值,AUC为0.665(95%CI 0.533-0.797)。
  • 双能CT定量模型与综合模型的AUC比较P=0.076,两者性能相当。

临床应用与阅片要点

  • 双能CT定量模型和综合模型的AUC均高于定性模型和常规CT定量模型(均P<0.05),可用于鉴别非富血供胰腺神经内分泌肿瘤与CA 19-9阴性胰腺导管腺癌。
  • 动脉期和门静脉期归一化碘浓度较高提示血供较丰富,有助于识别非富血供胰腺神经内分泌肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the utility of dual-energy CT (DECT) in differentiating non-hypervascular pancreatic neuroendocrine neoplasms (PNENs) from pancreatic ductal adenocarcinomas (PDACs) with negative carbohydrate antigen 19-9 (CA 19-9).

METHODS: This retrospective study included 26 and 39 patients with pathologically confirmed non-hypervascular PNENs and CA 19-9-negative PDACs, respectively, who underwent contrast-enhanced DECT before treatment between June 2019 and December 2021. The clinical, conventional CT qualitative, conventional CT quantitative, and DECT quantitative parameters of the two groups were compared using univariate analysis and selected by least absolute shrinkage and selection operator regression (LASSO) analysis. Multivariate logistic regression analyses were performed to build qualitative, conventional CT quantitative, DECT quantitative, and comprehensive models. The areas under the receiver operating characteristic curve (AUCs) of the models were compared using DeLong's test.

RESULTS: The AUCs of the DECT quantitative (based on normalized iodine concentrations [nICs] in the arterial and portal venous phases: 0.918; 95% confidence interval [CI] 0.852-0.985) and comprehensive (based on tumour location and nICs in the arterial and portal venous phases: 0.966; 95% CI 0.889-0.995) models were higher than those of the qualitative (based on tumour location: 0.782; 95% CI 0.665-0.899) and conventional CT quantitative (based on normalized conventional CT attenuation in the arterial phase: 0.665; 95% CI 0.533-0.797; all P < 0.05) models. The DECT quantitative and comprehensive models had comparable performances (P = 0.076).

CONCLUSIONS: Higher nICs in the arterial and portal venous phases were associated with higher blood supply improving the identification of non-hypervascular PNENs.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Hu X, Shi S, Wang Y, et al. Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas. Radiol Med. 2023. PMID: 37861978. doi:10.1007/s11547-023-01733-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。